Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suicidal behavior in schizophrenia.

Rajiv Tandon1

  • 1Department of Children and Families, Office of Mental Health, State of Florida, USA. rtandon@umich.edu

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond.

JAMA psychiatry·2026
Same author

Development of the Next <i>DSM</i>-Learnings From the <i>DSM-5</i> Experience.

The American journal of psychiatry·2026
Same author

The increasing incomprehensibility of medical research for clinicians.

Asian journal of psychiatry·2026
Same author

Changing your perspective on fatal outcomes in clozapine-treated patients. They do not die of agranulocytosis.

Asian journal of psychiatry·2026
Same author

Psychiatric nosology needs a new paradigm.

Asian journal of psychiatry·2026
Same author

The Asian Journal of Psychiatry: An end of year review 2025.

Asian journal of psychiatry·2026

Suicidal behavior is common in schizophrenia, especially early in the illness. Effective treatments for psychosis, depression, and substance abuse, along with hope and recovery, can reduce suicide risk.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Suicidal behavior presents a significant challenge in schizophrenia, with high prevalence throughout the illness course.
  • Key risk factors include psychosis, depression, substance abuse, and akathisia, alongside demoralization.

Purpose of the Study:

  • To elucidate the problem of suicidal behavior in schizophrenia.
  • To provide insights into clinical risk factors, neurobiological underpinnings, and effective treatment strategies.
  • To highlight advances in understanding and reducing suicidality.

Main Methods:

  • Review of recent investigations into suicidal behavior in schizophrenia.
  • Analysis of clinical risk factors, neurobiological correlates, and treatment impacts.

Related Experiment Videos

  • Evaluation of newer antipsychotics (e.g., clozapine) and psychologic approaches (e.g., cognitive behavioral therapy).

    • Main Results:

    • Suicide risk is highest early in schizophrenia but persists lifelong.
    • Effective management of positive symptoms, depression, substance abuse, and akathisia is crucial.
    • Atypical antipsychotics and cognitive behavioral therapy show promise in reducing suicidality.

    Conclusions:

    • Advances in neurobiology offer potential for more effective treatments.
    • Emphasis on resilience, recovery, and hope fosters optimism for reducing suicide in schizophrenia.
    • Continued research and momentum are expected to improve outcomes for individuals with schizophrenia.